Search Results

You are looking at 61 - 70 of 190 items for :

  • "Renal cell carcinoma" x
  • Refine by Access: All x
Clear All
Full access

Management of Metastatic Renal Cancer

Patricia Thompson and Mayer Fishman

. Immunotherapy of metastatic renal cell cancer . Review . Cancer Control 2002 ; 9 : 293 – 304 . 3 Motzer RJ Bander NH Nanus DM . Renal-cell carcinoma . N Engl J Med 1996 ; 335 : 865 – 875 . 4 Motzer RJ Mazumdar M Bacik J . Survival

Full access

Optimal Management of Small Renal Masses

Ralph Hauke

://www.cancer.org/downloads/STT/CAFF2006PWSecured.pdf . Accessed September 12, 2006 . 2. Chow WH Devesa SS Warren JL Fraumeni JF Jr . Rising incidence of renal cell carcinoma in the United States . JAMA 1999 ; 281 : 1628 – 1631 . 3. Hock LM Lynch J Balaji KC

Full access

Kidney Cancer, Version 2.2014

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Clair Beard, Sam Bhayani, Graeme B. Bolger, Sam S. Chang, Toni K. Choueiri, Ithaar H. Derweesh, Shilpa Gupta, Steven L. Hancock, Jenny J. Kim, Timothy M. Kuzel, Elaine T. Lam, Clayton Lau, Ellis G. Levine, Daniel W. Lin, Kim A. Margolin, M. Dror Michaelson, Thomas Olencki, Roberto Pili, Elizabeth R. Plimack, Edward N. Rampersaud, Bruce G. Redman, Charles J. Ryan, Joel Sheinfeld, Kanishka Sircar, Brad Somer, Jue Wang, Richard B. Wilder, Mary A. Dwyer, and Rashmi Kumar

estimated 63,920 Americans will be diagnosed with renal cancer and 13,860 will die of the disease in the United States in 2014. 1 Renal cell carcinoma (RCC) comprises approximately 3.9% of new cancers, with a median age at diagnosis of 64 years. The rate of

Full access

Localized Renal Cell Cancer: A Testing Ground for New Approaches and Technology

Rodger J. Winn

costs and length of stay for radical nephrectomy versus nephron-spring surgery in the management of localized renal cell carcinoma . Urology 1999 ; 54 : 994 - 998 . 3 Clark PE Schover LR Uzzo RG . Quality of life and psychological

Full access

Letter to the Editor: T1a 0- to 2-cm Small Renal Masses

Boda Guo and Ming Liu

Pecoraro et al 1 titled “Small Renal Masses With Tumor Size 0 to 2 cm: A SEER-Based Study and Validation of NCCN Guidelines.” The authors summarized the characteristics of T1a 0- to 2-cm renal cell carcinoma (RCC). It deals with a significant clinical

Full access

Authors’ Reply: To Letter to the Editor by Guo and Liu

Angela Pecoraro, Francesco Porpiglia, and Pierre I. Karakiewicz

We thank Guo and Liu for making these important considerations. As stated in our study, 1 our aim was to reexamine surgically treated patients with renal cell carcinoma (RCC) with T1a renal tumors 0–2 cm to better elucidate the distribution of

Full access

Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Sam Bhayani, William P. Bro, Sam S. Chang, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Mayer Fishman, Thomas H. Gallagher, John L. Gore, Steven L. Hancock, Michael R. Harrison, Won Kim, Christos Kyriakopoulos, Chad LaGrange, Elaine T. Lam, Clayton Lau, M. Dror Michaelson, Thomas Olencki, Phillip M. Pierorazio, Elizabeth R. Plimack, Bruce G. Redman, Brian Shuch, Brad Somer, Guru Sonpavde, Jeffrey Sosman, Mary Dwyer, and Rashmi Kumar

estimated 62,700 Americans were diagnosed with renal cancer and 14,240 died of the disease in 2016. 1 Renal cell carcinoma (RCC) constitutes approximately 3.8% of all new cancers, with a median age at diagnosis of 64 years. Approximately 90% of renal tumors

Full access

NCCN Guidelines® Updates: Kidney Cancer

surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial. Lancet Oncol 2016;17:1317-1324. Harrison MR, et al. Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC). Cancer. 2021 Mar

Full access

Kidney Cancer

Robert J. Motzer, Neeraj Agarwal, Clair Beard, Sam Bhayani, Graeme B. Bolger, Michael A. Carducci, Sam S. Chang, Toni K. Choueiri, Steven L. Hancock, Gary R. Hudes, Eric Jonasch, David Josephson, Timothy M. Kuzel, Ellis G. Levine, Daniel W. Lin, Kim A. Margolin, M. Dror Michaelson, Thomas Olencki, Roberto Pili, Thomas W. Ratliff, Bruce G. Redman, Cary N. Robertson, Charles J. Ryan, Joel Sheinfeld, Philippe E. Spiess, Jue Wang, and Richard B. Wilder

. Participation in clinical trials is especially encouraged. Overview An estimated 58,240 Americans were diagnosed with renal cancer and 13,040 died of the disease in the United States in 2010. 1 Renal cell carcinoma (RCC) constitutes 2% to 3% of all

Full access

NCCN News

awarded 6 independent grants to health care institutions following a joint request for proposals (RFP) focused on the development and adoption of evidence-based initiatives to improve patient care and outcomes in renal cell carcinoma and hematologic